Welcome to LookChem.com Sign In|Join Free
  • or
2,2',4'-Trihydroxychalcone is a natural flavonoid compound derived from various plant species. It is characterized by its antioxidant and anti-inflammatory properties, which make it a promising candidate for pharmaceutical and nutraceutical applications. 2,2',4'-TRIHYDROXYCHALCONE has been studied for its potential therapeutic effects in treating diabetes, cancer, and neurodegenerative diseases. Its ability to modulate various signaling pathways within the body highlights its potential for further exploration and development in the medical field.

26962-50-5

Post Buying Request

26962-50-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26962-50-5 Usage

Uses

Used in Pharmaceutical Applications:
2,2',4'-Trihydroxychalcone is used as a therapeutic agent for its potential role in treating various conditions such as diabetes, cancer, and neurodegenerative diseases. Its antioxidant and anti-inflammatory properties contribute to its potential efficacy in managing these conditions.
Used in Nutraceutical Applications:
In the nutraceutical industry, 2,2',4'-Trihydroxychalcone is used as a dietary supplement or functional food ingredient due to its health-promoting properties. Its antioxidant and anti-inflammatory effects can support overall health and well-being.
Used in Antioxidant Formulations:
2,2',4'-Trihydroxychalcone is used as an antioxidant in various formulations, such as cosmetics, food products, and pharmaceuticals, to protect against oxidative stress and prevent cellular damage.
Used in Anti-Inflammatory Agents:
Due to its anti-inflammatory properties, 2,2',4'-Trihydroxychalcone is used as an anti-inflammatory agent in the development of medications for conditions characterized by inflammation, such as arthritis and other inflammatory disorders.
Used in Research and Development:
2,2',4'-Trihydroxychalcone is utilized in research settings for further exploration of its biological effects and potential applications. Its ability to modulate signaling pathways makes it a valuable compound for studying the underlying mechanisms of various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 26962-50-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,9,6 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 26962-50:
(7*2)+(6*6)+(5*9)+(4*6)+(3*2)+(2*5)+(1*0)=135
135 % 10 = 5
So 26962-50-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H12O4/c16-11-6-7-12(15(19)9-11)14(18)8-5-10-3-1-2-4-13(10)17/h1-9,16-17,19H/b8-5+

26962-50-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2,4-dihydroxyphenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names Chalcone,2,2',4'-trihydroxy-(6CI,8CI)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:26962-50-5 SDS

26962-50-5Relevant academic research and scientific papers

Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia

Xie, Zhaodi,Luo, Xiaoting,Zou, Zhuan,Zhang, Xiao,Huang, Feifei,Li, Ruishan,Liao, Shijie,Liu, Yun

, p. 3602 - 3606 (2017/07/07)

A series of hydroxychalcone derivatives have been designed, synthesized and evaluated for human xanthine oxidase (XO) inhibitory activity. Most of the tested compounds acted moderate XO inhibition with IC50 values in the micromolar rang. Molecular docking and kinetic studies have been performed to explain the binding modes of XO with the selected compounds. In addition, in vitro antioxidant screening results indicated that some of the hydroxychalcones possessed good anti-free radical activities. Furthermore, the preferred compounds 16 and 18 were able to significantly inhibit hepatic xanthine oxidase activity and reduced serum uric acid level of hyperuricemic mice in vivo. In summary, compounds 16 and 18 with balanced activities of antioxidant, XO inhibition and serum uric acid reduction, which are promising candidates for the treatment of hyperuricemia and gout.

Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1)

Ma, Lei,Yang, Zhengyi,Li, Chenjing,Zhu, Zhiyuan,Shen, Xu,Hu, Lihong

, p. 643 - 648 (2012/04/10)

According to the structural characteristics of isoliquiritigenin from Glycyrrhiza uralensis, a series of hydroxychalcones has been designed, synthesized and evaluated for their in vitro inhibitory activities of β-secretase (BACE1). Structure-activity relationship study suggested that inhibitory activity against BACE1 was governed to a greater extent by the hydroxyl substituent on A-and B-ring of the chalcone, and the most active compound was substituted with four hydroxyl group (17, IC50=0.27 μM).

Synthesis, biological evaluation and in silico metabolic and toxicity prediction of some flavanone derivatives

Moorthy, Narayana Subbiah Hari Narayana,Singh, Rahul Jitendra,Singh, Hemendra Pratap,Gupta, Sayan Dutta

, p. 1384 - 1390 (2007/10/03)

Flavones chemically are anthoxanthins, occur either in the free state or as glycosides associated with tannins (flavanoids). Flavanoids (derivatives of flavone) possess various pharmacological activities and due to its xanthine-oxidase enzyme inhibitory effect it also has superoxide-scavenging activities. A series of 2-phenyl-2,3-dihydrochromon-4-one derivatives (flavanone derivatives) were synthesized from chalcones by cyclization method and their activities were evaluated against some gram positive and gram-negative bacteria. IR, NMR and CHN analysis confirmed the structure of the synthesized compounds. The results of the antibacterial studies shows that compounds 2b, 2e, 2f and 2h possess activity against many bacterial strains. Among that the compound (2h) has remarkable activity against all strains viz. 25 μg/ml inhibitory concentration against S. aureus, S. sonnei, E. coli, S. typhimurium and V. cholerae. Compound 2f possess minimum inhibitory concentration of 200 μg/ml against E. coli and S. typhimurium and 25 μg/ml against S. sonnei, S. dysenteriae and V. cholerae. In silico metabolic and toxicity study of the synthesized compounds were performed and the predicted result showed that the compound having hydroxyl functional group undergo sulfate and O-glucuronide conjugation reaction and methoxy derivatives undergo demethylation reaction. The biologically active compounds are free of toxicity in oncogene, teratogen, sensitivity and immunotoxicity.

Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues

Lim, Soon Sung,Jung, Sang Hoon,Ji, Jun,Shin, Kuk Hyun,Keum, Sam Rok

, p. 653 - 668 (2007/10/03)

Aldose reductase, the key enzyme of the polyol pathway, and oxidative stress are known to play important roles in the complications of diabetes. A drug with potent inhibition of aldose reductase and oxidative stress, therefore, would be a most promising drug for the prevention of diabetic complications. The purpose of this study was to develop new compounds with these dual-effects through synthesis of chalcone derivatives and by examining the structure-activity relationships on the inhibition of rat lens aldose reductase as well as on antioxidant effects. A series of 35 flavonoid derivatives were synthesized by Winget's condensation, oxidation, and reduction of appropriate acetophenones with appropriate benzaldehydes. The inhibitory activity of these derivatives on rat lens aldose reductase and their antioxidant effects, measured using Cu2+ chelation and radical scavenging activities on 1,1-diphenyl-picrylhydrazyl in-vitro, were evaluated. Their effect on sorbitol accumulation in the red blood cells, lenses and sciatic nerves of streptozotocin-induced diabetic rats was also estimated. Among the new flavonoid derivatives synthesized, those with the 2′,4′-dihydroxyl groups in the A ring such as 2,4,2′,4′-tetrahydroxychalcone (22), 2,2′,4′-trihydroxychalcone (11), 2′,4′-dihydroxy-2,4-dimethylchalcone (21) and 3,4,2′,4′-tetrahydroxychalcone (18) were found to possess the highest rat lens aldose reductase inhibitory activity in-vitro, their IC50 values (concentration of inhibitors giving 50 % inhibition of enzyme activity) being 1.6 × 10-7, 3.8 × 10-7, 4.0 × 10-7 and 4.6 × 10-7 M, respectively. All of the chalcones tested except 3, 18, 23 with o-dihydroxy or hydroquinone moiety showed a weak free radical scavenging activity. In the in-vivo experiments, however, compound 18 with o-dihydroxy moiety in the B ring showed the strongest inhibitory activity in the accumulation of sorbitol in the tissues. It also showed the strongest activity in transition metal chelation and free radical scavenging activity. Of the 35 4,2′-dihydroxyl and 2′,4′-dihydroxyl derivatives of flavonoid synthesized, including chalcone, flavone, flavanone, flavonol and dihydrochalcone, some chalcone derivatives synthesized were found to possess aldose reductase inhibition and antioxidant activities in-vitro as well as inhibition in the accumulation of sorbitol in the tissues in-vivo. 3,4,2′,4′-Tetrahydroxychalcone (18, butein) was the most promising compound for the prevention or treatment of diabetic complications.

Studies in cell suspension cultures of cassia didymobotrya. Part VI. The biotransformation of chalcones to aurones and auronols

Botta, Bruno,Delle Monache, Giuliano,De Rosa, Maria Cristina,Scurria, Rosalba,Vitali, Alberto,Vinciguerra, Vittorio,Menendez, Pilar,Misiti, Domenico

, p. 1415 - 1421 (2007/10/03)

Cell-free extracts derived from tissue cultures of Cassia didymobotrya, which previously had been reported to convert 4-hydroxychalcones to flavones and biflavanones, catalyze the biotransformation of 2-hydroxychalcones to aurones and auronols. The aurone

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 26962-50-5